General Nuclear Medicine scans (Gamma/SPECT)

• Gamma/SPECT
• Thyroid Scan
• Parathyroid Scan
• Myocardial Perfusion Scan
• Hepatobiliary Scan (HIDA)
• LUNG Scan (V/Q)
• Milk Scan (GER)
• Gastric Emptying Study
• Gastrointestinal Bleed
• Meckel’s Scan
• Renal Scan (DTPA, EC, DMSA, DRCG)
• Liver-Spleen Scan
• Bone Scan
• Sentinel Lymph Node Imaging
• Lymphoscintigraphy
• Neurology (Epilepsy, Parkinson’s Disease)

PET/CT scans

• 18F-FDG – oncology (diagnosis, staging, restaging, response to therapy, follow up) and non-oncology (granulomatous disease, vasculitis, cardiac viability etc)
• 18F – DOTATATE/NOC- neural crest derived tumours (NET, MCT, PGL, Pheo, neuroblastoma, TIO etc)
• 18F– FAPI – excellent tracer for most of the malignancies.
• 68Ga – EXENDIN- insulinoma
• 18F – PSMA- prostate cancer (diagnosis, staging, restaging, response to therapy, follow up)

• High dose I-131 for treatment of differentiated thyroid carcinoma.
• Low dose I-131 for treatment of thyrotoxicosis – Graves’ disease, Toxic MNG, AFTN
• Peptide receptor radionuclide therapy (PRRT) for patients with Metastatic Neuroendocrine Tumor, TENIS (thyroglobulin elevated negative iodine scintigraphy), MCT
• PSMA radioligand therapy for patients with metastatic castration resistant prostate carcinoma
• Palliative bone pain therapy.
• I-131 MIBG therapy for malignant pheochromocytoma, metastatic neuroblastoma, paraganglioma, MCT
• Radiosynovectomy-chronically inflamed joints, refractory to treatment
• TARE-Treatment of primary and secondary hepatic malignancies